Atopic dermatitis (AD) is a common skin disease characterized by pruritus, eczematous skin lesions, and a chronically relapsing course.
It has been accepted that topical steroid therapy is crucial for AD management, but they cannot be used for long periods because of frequent side effects. Steroid therapy can improve topical cutaneous symptoms, but cannot completely cure the disease. Many patients therefore choose to explore complementary/alternative medicines including herbal medicine. 5) Traditional Chinese medicine (TCM) and traditional Japanese medicine (Kampo) have been receiving increasing attention as alternative sources of treatment for chronic diseases, including AD. TCM is believed to have the potential to treat patients holistically by supporting the patient's selfhealing power. 6, 7) However, the dearth of scientific evidence of TCM has restricted its polular use.
A murine strain, NC, is a well-known animal model for AD and has been extensively used to elucidate AD pathogenesis and development. NC mice spontaneously develop ADlike eczematous skin lesions with IgE hyperproduction when raised under conventional conditions, but not under specific pathogen-free conditions. 8) It was revealed that environmental antigens such as Dermatophagoides farinae (Df) were involved in the pathogenesis of AD-like symptoms in NC mice. Repeated extraneous injections of the antigen to NC mice caused severe and settled dermatitis, which could then be used as a model to evaluate new pharmaceutics for AD treatment. [9] [10] [11] We evaluated the effect of bakumijiogan (BJG) on the AD model induced by repeated Df-antigen injections in NC/Jic mice. BJG is a modified herbal formula of rokumigan. Rokumigan consists of six crude drugs (Table 1) and is a basic formula used to treat kidney-yin deficiency, which according to the TCM theory is a condition characterized by tidal fever, spontaneous sweating, dizziness, tinnitus, spermatorrhea (in males), and sexual intercourse in dream (in famales). Six crude drugs contained in rokumigan and two additional crude drugs, ophiopogon tuber (bakumondo in Japanese, B) and schisandra fruit (gomishi in Japanese, G), constitute BJG (Table 1 ). In the TCM theory, the targeted conditions for BLG use include deficiency of lung-kidney-yin, reversed flow of qi, tidal fever, and night sweats. BJG has therefore been given to patients with asthma, AD, or systemic lupus erythematosus. 12) 
MATERIALS AND METHODS

Preparation of Herbal Formulas
All crude drugs in the Japanese Pharmacopoeia XV 13) were purchased from Tsumura Co. Ltd. (Tokyo). The composition of BJG and related formulas are shown in Table 1 . Each dried herbal mixture of the formula was boiled in 20-times weight of distilled water for 60 min. Decoctions were lyophilized and the powder was maintained at room temperature under desiccated conditions until use. Yields of the extract from herbal medicines are shown in Table 1 . To prepare the sample for the animal experiments, lyophilized powder was suspended in distilled water at appropriate proper concentrations. The dose of each herbal formula is shown in Table 1 , which was equivalent to ten-fold value of the human dosage.
An HPLC fingerprint of BJG is shown in Fig. 1 . Lyophilized powder of BJG (0.5 g) was extracted with MeOH (10 ml) by sonication for 30 min, and the supernatant (25 ml) was subjected to HPLC at the following conditions: system, Shimadzu LC-10A VP (Kyoto); column, TSK-GEL ODS-80 TS (4.6ϫ250 mm, Tosoh, Tokyo); mobile phase, 0.05 M AcOH-AcONH 4 buffer (pH 3.6)/CH 3 CN 90 : 10 (0 min)→ 0 : 100 (80 min), linear gradient; flow rate, 1.0 ml/min; column temperature, 40°C; and detection, 200-400 nm by a photodiode array detector.
Animal Experiments Experimental procedures were approved by the Animal Care Committee at Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, in accordance with the guidelines of the Japanese Council on Animal Care.
Male NC/Jic mice (7-8 week old) were purchased from Clea Japan Inc. (Tokyo). They were housed in a temperaturecontrolled room (at 23Ϯ1°C) with lighting from 7 a.m. to 7 p.m. and freely access to food (CE-2, Oriental Yeast, Tokyo) and water under conventional conditions. Standardized mite D. farinae allergenic extract (1 : 100 (w/v), endotoxin-free) (Greer, Lenoir, NC, U.S.A.) was diluted to 1 mg/ml by saline, and cutaneously injected into the right ear (10 ml/ear) on days 0 (first injection), 2, 4, 7, 9, 11, 14, and 16. Herbal extracts were orally administered daily from 7 d before to 16 d after the first injection. The normal group did not receive cutaneous injections, and were orally administered distilled water (10 ml/kg body weight). The vehicle group was treated with cutaneous injections of saline into the right ear and gavage of distilled water. For the control group, distilled water was gavaged instead of herbal extracts every day. Ear thickness was measured using a dial thickness gage (Peacok model G-1A, Ozaki MFJ, Tokyo) 1 and 24 h after injection, and data were recorded as the difference from the values before the first injection. Mice were sacrificed by excessive anesthesia with ether on day 17. Serum, postauricular lymph node, and ear samples were collected.
Enzyme-Linked Immunosorbent Assay (ELISA) for Serum Immunoglobulins and Interferon (IFN)-g g Total serum IgE concentrations were measured by sandwich ELISA using 96-well assay plates (Sumitomo Bakelite, Tokyo). Wells were coated with purified anti-mouse IgE (2 mg/ml, BD Biosciences, Flanklin Lakes, NJ, U.S.A.). After blocking with a 0.5% solution of bovine serum albumin, sample or standard murine IgE (BD Biosciences) was added to wells. The amount of IgE bound to a well was indirectly assayed by using 1 : 1000 dilution of avidin-horseradish peroxidase (HRP) (BD Biosciences) via biotinylated anti-mouse IgE (0.5 mg/ml, BD Biosciences). Concentration of total IgE was calculated by the calibration curve of standard mouse IgE.
Serum concentrations of Df-antigen-specific IgG 1 and IgG 2a were assayed by sandwich ELISA using a Falcon 96-well immunoplate (BD Biosciences). Wells were coated with Df-antigen solution (50 mg/ml in 0.15 M phosphate-buffered saline, pH 7.2), and samples were detected with 1 : 20000 di- (Bethyl) . Data were expressed as the titer calculated by the standard murine anti-Df-antigen serum, which was prepared according to the method of Inagaki et al. 14) with slight modifications. Briefly, Df-antigen was suspended in a 10 mg/ml Al(OH) 3 solution (final concentration of Df-antigen, 100 mg/ml), and 0.2 ml of this suspension was injected intraperitoneally into 4-weekold female Balb/c mice (Japan SLC, Hamamatsu) six times at 2-week intervals. Whole blood was collected 7d after the sixth injection.
Serum IFN-g concentrations were measured using a commercial kit (Quantikine Mouse IFN-g Immunoassay kit, R&D Systems, Minneapolis, MN, U.S.A.) according to the manufacturer's instructions. Detection limit was Ͼ0.5 pg/ml.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA was extracted from about 30 mg of pooled ear samples in each group using TRIzol reagent (Invitrogen, Carlsbad, CA, U.S.A.). DNAse I (Promega, Madison, WI, U.S.A.)-treated RNA (500 ng) was reverse-transcribed using 100 unit of reverse transcriptase (ReverTra Ace, Toyobo, Osaka) with 0.1 mM oligo(dT) primer in a total volume of 20 ml. An aliquot (2 ml) of the RT mixture was used for PCR with 1 unit AmpliTaq Gold (Applied Biosystems, Foster City, CA, U.S.A.) and 10 mM primers. Primer sequences are shown in Table 2 . The amplification program consisted of one cycle at 94°C for 10 min, and the cycles shown in Table 2 at 95°C for 30 s, followed by annealing at various temperatures (Table 2) for 30 s and 72°C for 30 s. PCR products were resolved on 1.5% agarose gels and visualized by ethidium bromide staining.
Quantitative RT-PCR Real-time RT-PCR was performed on an ABI PCR7300 System (Applied Biosystems) using two-fold diluted Power SYBR Green PCR Master Mix (Applied Biosystems). Primer sequences were obtained from an online library and are shown in Table 3 . DCt was determined by subtracting the mean cycle threshold (Ct) of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from that of the targeted cytokines. Data were expressed as the fold change to the level of control mice.
Statistical Analyses Statistical analyses were conducted by repeated one-way analysis of variance (ANOVA), combined with Dunnet's multiplex comparison analysis. A probability value of less than 0.05 was considered statistically significant.
RESULTS
Intradermal injection of Df-antigen into the ears of NC/Jic mice (control group) resulted in significantly greater ear swelling one day after the first injection compared with vehicle-injected mice (vehicle group). The ear auricle in the control group presented with a reddish-colored wound and dried skin seven days after the first injection, and these symptoms were augmented daily. Compared with the normal group (not injected), the vehicle group showed slightly greater ear swelling 12 d post-injection. On day 17, the weight of the postauricular lymph node in the control group was significantly higher than that of the normal and vehicle groups (normal, 1.9Ϯ0.5 mg; vehicle, 2.3Ϯ0.8 mg; control, 6.8Ϯ1.4 mg). Ear swelling of BJG-treated mice was lower than control over the experimental period of 17 d, and the suppression was statistically significant (pϽ0.01) until day 7 (Fig. 2a) . The area under the curve of ear swelling from days 0 to 17 was significantly reduced to 68% of that of the control group (pϽ0.05) by BJG administration (Fig. 2b) . Hypertrophy of the postauricular lymph node on day 17 was not significantly reduced by BJG administration (BJG group, 6.6Ϯ0.9 mg).
Serum concentrations of total IgE, Df-specific IgG 1 and IgG 2a were measured on day 17. Control mice exhibited significantly higher serum concentrations of total IgE, Df-specific IgG 1 and IgG 2a compared with normal and vehicle groups. Serum concentrations of total IgE and Df-specific IgG 1 in BJG-treated mice were slightly lower than in control, whereas serum Df-specific IgG 2a in BJG-treated mice was slightly higher than in control (Table 4) .
While Df-antigen injection did not affect the serum concentration of IFN-g, it was significantly elevated in BJGtreated mice (Fig. 3a) . IFN-g mRNA expression in the ear was slightly induced by treatment with Df-antigen, and mRNA levels were further increased in BJG-treated mice (Fig. 3b) . Changes in IFN-g mRNA expression paralleled serum IFN-g levels.
mRNA levels of the inflammatory cytokines IL-4, IL-1a and tumor necrosis factor (TNF)-a in the ear of control 2110 Vol. 31, No. 11 group were higher than those in the normal and vehicle groups. In BJG-treated mice, IL-4 mRNA expression was slightly higher, whereas IL-1a and TNF-a mRNA expressions were lower than those in the control group (Figs. 3b, c) . We identified the herbal ingredients contributing to the suppressive effect of BJG on AD-like symptoms. We administered rokumigan, BJG (rokumiganϩBϩG), rokumiganϩB, rokumiganϩG, and BϩG (Table 1) to the mice. Ear swelling of NC mice administered rokumigan was temporarily lower than that in the control group on days 3 and 9 (data not shown), but total suppression of ear swelling was not observed. Neither rokumiganϩB nor rokumiganϩG showed significant suppression of ear swelling, whereas BϩG significantly suppressed the ear swelling of NC mice (pϽ0.01), and suppression was comparable with that caused by BJG (Fig.  4) .
DISCUSSION
We showed that BJG significantly suppressed the development of AD-like symptoms induced by repeated injections of Df-antigen in NC mice. Df-antigen contains Der f1 as a major antigen, which inhibits endogeneous protease inhibitors and disrupts the integrity of interepithelial tight junctions 15, 16) in order to degrade the dermal barrier function, resulting in the development of AD-like symptoms in NC mice. AD-like symptoms are characterized by severe ear swelling with a thickened epidermis, eosinophil infiltration, fibrosis of the dermis, and high IgE titer in serum, all of which resembled human AD. 9) Most patients suffering from AD have a higher serum concentration of IgE, and Df-antigen-specific Th2 cells are detected in peripheral blood.
17) The Th2 condition has the tendency to produce IL-4, histamine, and IgE. 18, 19) In the present NC mouse model, repeated injections of Df-antigen into the ear auricle resulted in IgE hyperproduction with upregulation of IL-4 and TNF-a mRNA levels at the lesion site. These changes in cytokine levels are similar to those of AD patients. 20, 21) BJG prevented the increase of neither IL-4 mRNA levels at the lesion site nor serum IgE and Df-antigen-specific Ig levels. BJG significantly increased serum IFN-g levels, which is a Th1 cytokine. Although IL-4 expression in the ear was only slightly increased by BJG treatment, IFN-g expression notably increased in the ear, while IL-1a and TNFa expressions were slightly decreased. These results suggest that BJG corrects the Th1/Th2 balance skewed toward Th2 by predominantly promoting systemic Th1 functions, which led to the improvement of ear swelling presumably through simultaneous decrease in IL-1a and TNF-a at the lesion site.
Gao et al. examined the effects of four herbal formulas in Kampo or TCM, hochuekkito, juzentaihoto, shofusan and orengedokuto, on NC/Nga mouse dermatitis model by repeated painting of Df-antigen solution on the ears after tape stripping. 22) All herbal formulas effectively suppressed dermatitis, and prevented increase of IL-4 mRNA expression and decrease of IFN-g levels. Juzentaihoto and hochuekkito also inhibited IgE hyperproduction. The four herbal formulas previously reported and BJG in the present investigation suppressed the AD-like symptoms induced by Df-antigen in NC mice through essentially the same mechanism, i.e., correction of Th1/Th2 imbalance, although the four herbal formulas have been used to treat qi deficiency syndromes or internal heat syndrome, and the clinical indications are quite different from those of BJG.
The result that rokumigan containing six crude drugs failed to suppress ear swelling in NC mice suggests that the additional two crude drugs, which are not contained in rokumigan but in BJG, play an important role in the suppression of AD-like symptoms. The extract prepared from the mixture of ophiopogon tuber and schisandra fruit exhibited a suppressive effect on AD-like symptoms in NC mice, whereas rokumiganϩophiopogon tuber and rokumiganϩschisandra fruit were not effective against dermatitis. It is suggested that the combination of ophiopogon tuber and schisandra fruit may be important to suppress AD-like symptoms. In the TCM theory, ophiopogon tuber and schisandra fruit are used to promote body fluid production, 6) and they are sometimes prescribed together in several TCM formulas (e.g., shomyakusan and seisyoekkito). The present study could provide evidence for the combination and synergism of these two crude drugs. Previous studies have shown that each single crude drug would have anti-inflammatory effects in mice: water extract of ophiopogon tuber was reported to exhibit an inhibitory effect on xylene-induced ear swelling and carrageenan-induced paw edema. 23) Schizandrin, a constituent of schisandra fruit, was shown to suppress passive anaphylaxis and itching. 24) Little is known about the synergistic effects of these two crude drugs, and further studies are required.
In conclusion, BJG suppressed AD-like symptoms in NC mice repeatedly injected with Df-antigen into the ear auricle by correcting the Th1/Th2 imbalance skewed toward Th2. The combination of two herbal ingredients, ophiopogon 2112 Vol. 31, No. 11 tuber and schisandra fruit, mainly contributed to the effects of BJG.
